Portfolio Company Job Board

Find a job at one of our innovative portfolio companies
Sands Capital
82
companies
4,024
Jobs
Acumen Pharmaceuticals
Acumen Pharmaceuticals
acumenpharm.com

Locations

Carmel, IN, USA · Charlottesville, VA, USA

industry

Biotechnology · DeepTech · Health

Size

51-200 employees

Stage

Other

founded in

1996

Acumen is a clinical-stage biopharmaceutical company developing a novel disease-modifying approach to target amyloid-beta oligomers, (AβOs), which Acumen believes to be a key underlying cause of Alzheimer’s disease, or AD. Acumen is currently focused on advancing a targeted immunotherapy drug candidate, ACU193, to establish proof of mechanism in early AD patients. Acumen initiated its Phase 1 clinical trial of ACU193 in the second quarter of 2021 with the objective to evaluate its safety and tolerability and explore its pharmacokinetics and target engagement. This trial is currently enrolling patients with mild cognitive impairment and mild dementia due to AD. ACU193 Phase 1 data intended to evaluate safety and tolerability and demonstrate clinical proof of mechanism are expected by year end 2022.

Something looks off?
Open jobs at Acumen Pharmaceuticals

On-site & Remote